Hypoglycemia
📧 Sign up to get email alerts when something new happens for Hypoglycemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM [Phase 3]
A Phase 3 trial comparing two batches of subcutaneous dasiglucagon in adults with type 1 diabetes to assess efficacy and safety for hypoglyc…
-
FDA approval · 2022-12-22FDA Approved: PROGLYCEM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for PROGLYCEM (diazoxide) submitted by Teva Pharmaceuticals USA, Inc., resulting in a label/indicati…
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes [Phase 2]
Phase 2 trial evaluating pen-administered low-dose dasiglucagon for prevention and treatment of hypoglycemia in people with type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes [Phase 4]
Phase 4 clinical trial update on dual-hormone closed-loop glucose control for Type 1 diabetes, with consideration of hypoglycemia outcomes.
-
FDA approval · 2022-07-14FDA Approved: GLUCAGON — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for Glucagon submitted by Fresenius Kabi USA, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery [Phase 4]
Phase 4 clinical trial evaluating pramlintide (Symlin) for treating hypoglycemia after gastric bypass surgery has completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2022-01-21Clinical Trial Update: Intravenous Exenatide (Byetta) During Surgery [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating intravenous exenatide (Byetta) during surgery; results have been posted after completion.
-
FDA approval · 2021-08-20FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Supplemental Application (Xeris Pharmaceuticals, Inc.)
FDA approves a supplemental application for GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR, a glucagon injection solution, expanding its device format f…
-
FDA approval · 2021-07-29FDA Approved: GLUCAGON — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for the glucagon product from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy
Clinical trial update on glial pathways to hypoglycemia-associated autonomic failure (HAAF) in humans using carbon-13 magnetic resonance spe…
-
FDA label_change · 2021-07-15FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Supplemental Application (Xeris Pharmaceuticals, Inc.)
FDA approved a supplemental application for GVOKE HYPOPEN 0.5 mg auto-injector (glucagon injection, solution) by Xeris Pharmaceuticals, upda…
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM [Phase 3]
Phase 3 trial assessing dasiglucagon for treatment of hypoglycemia in type 1 diabetes completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children [Phase 3]
A Phase 3 trial completed evaluating dasiglucagon for treating hypoglycemia in children with type 1 diabetes; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects [Phase 3]
Phase 3 trial evaluating dasiglucagon for treating hypoglycemia in adults with type 1 diabetes completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicine Departments With Nutritional Care [Phase 3]
Phase 3 trial update focused on preventing hypoglycemia in diabetes patients admitted to internal medicine departments with nutritional care…
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: Insulin Tolerance Test Study in Patients With Type 1 Diabetes [Phase 1]
Phase 1 trial update for an insulin tolerance test in patients with Type 1 diabetes; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus [Phase 3]
Phase 3 trial assessing immunogenicity of dasiglucagon and GlucaGen in people with Type 1 diabetes; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes [Phase 2]
Phase 2 trial assessing low-dose dasiglucagon to prevent insulin-induced hypoglycemia in people with type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Mechanisms of Hypoglycemia Associated Autonomic Failure [Phase 2]
Phase 2 clinical trial update on mechanisms of hypoglycemia-associated autonomic failure in diabetes patients.
-
FDA approval · 2020-12-28FDA Approved: GLUCAGON — Original Application (Amphastar Pharmaceuticals, Inc.)
The FDA approved Amphastar Pharmaceuticals' original application for a generic glucagon product to treat severe hypoglycemia in patients wit…
-
CLINICAL_TRIALS withdrawal · 2020-07-31Clinical Trial Update: Lactate to Treat Hypoglycemia [Phase 4]
Phase 4 trial investigating lactate to treat hypoglycemia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-07-02Clinical Trial Update: Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and Dysglycemia [Phase 4]
Phase 4 trial comparing ciprofloxacin vs levofloxacin assessed effects on QTc interval and dysglycemia outcomes.
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes [Phase 3]
Phase 3 trial update comparing G-Pen to Glucagon Hypokit for severe hypoglycemia rescue in adults with type 1 diabetes; study completed with…
-
FDA approval · 2020-04-07FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Supplemental Application (Xeris Pharmaceuticals, Inc.)
The FDA approved a supplemental application for GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR (glucagon injection, solution) from Xeris Pharmaceuticals…
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Effect of Dapagliflozin on IAH in T1DM [Phase 2]
Phase 2 trial investigating the effect of dapagliflozin on impaired awareness of hypoglycemia in adults with type 1 diabetes; study complete…